Insider Transactions in Q2 2022 at Soc Telemed, Inc. (TLMD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 06
2022
|
Barbara Peterson Byrne |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
Thomas J. Carella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,591
-100.0%
|
$271,773
$3.0 P/Share
|
|
Apr 06
2022
|
Gyasi C. Chisley |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,150
-100.0%
|
$132,450
$3.0 P/Share
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
401,243
-100.0%
|
-
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
3,316,679
-100.0%
|
-
|
|
Apr 06
2022
|
Joseph P Greskoviak |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,185
-100.0%
|
$237,555
$3.0 P/Share
|
|
Apr 06
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,677
-100.0%
|
$47,031
$3.0 P/Share
|
|
Apr 06
2022
|
Eunice Kim General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,168
-100.0%
|
$66,504
$3.0 P/Share
|
|
Apr 06
2022
|
Amr Kronfol |
SELL
Sale (or disposition) back to the issuer
|
Direct |
101,325
-100.0%
|
$303,975
$3.0 P/Share
|
|
Apr 06
2022
|
Anne Mc George |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
David Mikula Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
496,576
-100.0%
|
$1,489,728
$3.0 P/Share
|
|
Apr 06
2022
|
Steven J Shulman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,112,291
-100.0%
|
$3,336,873
$3.0 P/Share
|
|
Apr 06
2022
|
Warburg Pincus & Co. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
67,749,930
-100.0%
|
$203,249,790
$3.0 P/Share
|
|
Apr 01
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,491
-7.32%
|
$12,982
$2.98 P/Share
|